Synopsys, Inc. $SNPS Shares Acquired by Union Bancaire Privee UBP SA

Union Bancaire Privee UBP SA boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 28.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 23,105 shares of the semiconductor company’s stock after buying an additional 5,115 shares during the quarter. Union Bancaire Privee UBP SA’s holdings in Synopsys were worth $9,656,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Aaron Wealth Advisors LLC lifted its holdings in Synopsys by 3.5% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 1,556 shares of the semiconductor company’s stock worth $694,000 after buying an additional 53 shares during the last quarter. MBL Wealth LLC acquired a new position in shares of Synopsys in the 2nd quarter worth approximately $277,000. Bar Harbor Wealth Management increased its holdings in shares of Synopsys by 3.4% in the 2nd quarter. Bar Harbor Wealth Management now owns 4,324 shares of the semiconductor company’s stock valued at $1,929,000 after acquiring an additional 143 shares during the last quarter. Waddell & Associates LLC bought a new stake in shares of Synopsys in the 2nd quarter valued at approximately $813,000. Finally, Independent Financial Group LLC raised its position in shares of Synopsys by 4.8% during the 2nd quarter. Independent Financial Group LLC now owns 800 shares of the semiconductor company’s stock valued at $357,000 after acquiring an additional 37 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have commented on SNPS. Stifel Nicolaus lifted their price objective on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Weiss Ratings reissued a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Rosenblatt Securities raised their price target on shares of Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a research report on Tuesday, May 26th. Benchmark began coverage on shares of Synopsys in a report on Wednesday, July 15th. They issued a “buy” rating and a $570.00 price target for the company. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $565.06.

More Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys’ AI initiatives across chip design, verification and simulation could improve customer productivity and reinforce its position in the semiconductor software market. This supports the long-term growth case, particularly as demand for AI chips expands. Can SNPS Leverage AI to Accelerate Chip Design and Drive Growth?
• Positive Sentiment: Recent coverage remains bullish on Synopsys’ potential to reach $650, citing approximately 42% revenue growth, raised guidance and the completed $35 billion acquisition. However, the price target is speculative and depends on investors assigning greater value to the company’s growth prospects. Prediction: Synopsys Will Hit $650 on This Date
• Positive Sentiment: Strength in memory and storage stocks, along with continued investor demand for semiconductor-focused ETFs, indicates that enthusiasm for AI and the broader chip ecosystem remains supportive for Synopsys’ electronic-design-automation business. Memory Stocks Stay Strong With SanDisk, SK Hynix, and Western Digital Leading the Storage Stack
• Neutral Sentiment: General Counsel Janet Lee is leaving the role but transitioning to an advisory position. The orderly handoff may limit disruption, although leadership changes can create near-term uncertainty. Synopsys Announces General Counsel Janet Lee’s Departure and Advisory Role Transition
• Negative Sentiment: Wells Fargo lowered its expectations for Synopsys’ stock, which can weigh on sentiment and reinforce concerns that the shares’ valuation does not yet reflect the company’s growth potential. Wells Fargo Has Lowered Expectations for Synopsys Stock Price
• Negative Sentiment: Fidelity’s warning that the semiconductor cycle may be nearing a peak introduces a broader sector risk. If chip spending or AI-related enthusiasm cools, high-growth suppliers such as Synopsys could face valuation pressure despite solid fundamentals. Semiconductor Flows Stay Sticky Despite Cycle-Peak Warning

Synopsys Trading Down 0.1%

NASDAQ:SNPS opened at $411.75 on Friday. The firm has a market capitalization of $78.84 billion, a P/E ratio of 95.31, a P/E/G ratio of 2.42 and a beta of 1.23. The business has a 50 day simple moving average of $426.49 and a 200 day simple moving average of $443.50. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. Synopsys, Inc. has a 12-month low of $366.00 and a 12-month high of $626.24.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm’s revenue for the quarter was up 41.9% on a year-over-year basis. During the same period last year, the company earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts predict that Synopsys, Inc. will post 10.65 EPS for the current year.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.